Skip to Main Content
March 27, 2020
Health Law Weekly

Featured Articles

Congressional Stimulus Package Includes Substantial Revisions to the Federal Confidentiality of Substance Use Disorder Patient Records (42 C.F.R. Part 2)

  • Gerald E. DeLoss, Illinois Association for Behavioral Health

COVID-19: Developments and Updates

Health Care Board COVID-19 Oversight Checklist

  • Michael Peregrine

How the COVID-19 Pandemic Immediately Impacts Clinical Trials: Considerations for Sites and Investigators

  • Kristen Rosati, Coppersmith Brockelman PLC
  • Amanda Coulter, Coppersmith Brockelman PLC

Current Topics

Antitrust

U.S. Court in Illinois Tosses Antitrust Action Against Mallinckrodt, Express Scripts

Coronavirus Pandemic Hub

Dispelling the Myths About HIPAA, Telehealth, and the Coronavirus

  • Rachel V. Rose, Rachel V. Rose—Attorney at Law PLLC

DOJ Shuts Down Website Selling Fraudulent COVID-19 Vaccine

FDA Will Allow Access to COVID-19 Convalescent Plasma for Possible Treatment of Critical Patients

Fraud and Compliance

Ninth Circuit Says FCA Doesn’t Require “Objective Falsity”

Government Reimbursement

U.S. Court in Connecticut Finds Appeal Rights for Certain Medicare Patients Challenging “Observation Status”

U.S. Court in DC Sides with Drug Maker in Medicaid Rebate Reclassification Suit

Health Insurance

U.S. Court in Massachusetts Dismisses Challenge to UnitedHealthcare’s Coverage Proton Beam Therapy Coverage Denial

Health Policy and Administration

National Health Spending Expected to Grow at Average 5.9% Clip Annually Through 2028

Patient Care Liability and Litigation

U.S. Court in Florida Boots Medical Records Action Back to State Court

Current Issue
Health Law Weekly Issue - March 27, 2020